IRIS
SCISCIOLA, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.451
NA - Nord America 2.062
AS - Asia 1.936
SA - Sud America 297
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 29
OC - Oceania 5
Totale 8.962
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.714
US - Stati Uniti d'America 1.983
IT - Italia 900
SG - Singapore 584
CN - Cina 412
VN - Vietnam 317
IE - Irlanda 313
HK - Hong Kong 252
BR - Brasile 247
DE - Germania 161
IN - India 128
KR - Corea 94
GB - Regno Unito 85
JP - Giappone 48
FR - Francia 47
NL - Olanda 38
DK - Danimarca 37
CA - Canada 32
TR - Turchia 29
FI - Finlandia 27
UA - Ucraina 22
CZ - Repubblica Ceca 18
AR - Argentina 17
PL - Polonia 16
AT - Austria 14
BD - Bangladesh 14
MX - Messico 14
SE - Svezia 14
PK - Pakistan 12
GR - Grecia 10
EC - Ecuador 8
ID - Indonesia 8
VE - Venezuela 8
CO - Colombia 6
ES - Italia 6
UZ - Uzbekistan 6
AU - Australia 5
HN - Honduras 5
IL - Israele 5
KE - Kenya 5
LT - Lituania 5
ZA - Sudafrica 5
BE - Belgio 4
CH - Svizzera 4
CR - Costa Rica 4
IQ - Iraq 4
MA - Marocco 4
NI - Nicaragua 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
LV - Lettonia 3
PE - Perù 3
PR - Porto Rico 3
SC - Seychelles 3
SV - El Salvador 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
GP - Guadalupe 2
JM - Giamaica 2
MY - Malesia 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CL - Cile 1
CY - Cipro 1
EG - Egitto 1
GL - Groenlandia 1
GT - Guatemala 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MR - Mauritania 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 8.780
Salva come PNG Salva come JPEG
Città #
Moscow 987
San Jose 399
Dublin 313
Singapore 303
Hong Kong 234
Naples 224
Ashburn 174
Santa Clara 169
Chandler 129
Council Bluffs 120
Hefei 104
Ho Chi Minh City 104
Bengaluru 97
Seoul 93
Dallas 84
Beijing 82
Hanoi 76
Munich 64
Caserta 51
The Dalles 49
Milan 48
Aversa 45
New York 39
Juelsminde 37
Jacksonville 35
Los Angeles 34
Princeton 28
Rome 26
Roxbury 26
Bremen 25
Amsterdam 23
Da Nang 21
Istanbul 20
Cambridge 19
Nuremberg 19
Turku 19
Brno 18
Napoli 17
São Paulo 17
Ercolano 16
North Bergen 14
Warsaw 13
Phoenix 12
Pomigliano d'Arco 12
Salerno 12
Wilmington 12
Chicago 10
Haiphong 10
Nha Trang 10
Boardman 9
Chennai 9
Medford 9
Miano 9
Orem 9
Tyresö 9
Atlanta 8
Bari 8
Biên Hòa 8
Bologna 8
Hillsboro 8
Kochi 8
Seattle 8
Vienna 8
Belo Horizonte 7
Brooklyn 7
Falkenstein 7
Florence 7
Giugliano in Campania 7
San Francisco 7
Denver 6
Frankfurt am Main 6
London 6
Manchester 6
Memphis 6
Mexico City 6
Montreal 6
Mountain View 6
Newark 6
Quảng Ngãi 6
Rio de Janeiro 6
Thái Nguyên 6
Boston 5
Brasília 5
Charlotte 5
Curitiba 5
Filderstadt 5
Fisciano 5
Houston 5
Lahore 5
Levate 5
Paris 5
Seregno 5
Sydney 5
Tashkent 5
Tokyo 5
Alghero 4
Ann Arbor 4
Barak 4
Boydton 4
Brussels 4
Totale 4.815
Salva come PNG Salva come JPEG
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 357
Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors 222
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 212
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 195
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin 194
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 194
Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study 185
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients 184
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 178
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts 173
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 171
Atherosclerotic plaque fissuration and clinical outcomes in pre-diabetics vs. normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of follow-up: Role of micrornas modulation: The atimir study 171
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors 170
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 169
Combined HAT/EZH2 modulation leads to cancer-selective cell death 169
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 166
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? 165
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 164
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 163
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 161
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 159
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide 158
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells 155
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 147
ATTIVATORI DI SIRTUINE E LORO USI 146
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia- exposed human cardiomyocytes through comprehensive multi-level analysis 145
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 145
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 145
New insight in molecular mechanisms regulating SIRT6 expression in diabetes: Hyperglycaemia effects on SIRT6 DNA methylation 142
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists 141
Obesity-induced neuronal senescence: Unraveling the pathophysiological links 141
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 140
Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line 139
miR-21 in Human Cardiomyopathies 139
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 138
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 138
Myocardial sodium–glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study 137
Evidence that tirzepatide protects against diabetes-related cardiac damages 135
Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complications 135
Tirzepatide prevents neurodegeneration through multiple molecular pathways 129
Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells 129
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes 128
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: Evidence in human cardiomyocyte cell line 121
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 120
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction 120
Current Preclinical Applications of Pharmaco-Epigenetics in Cardiovascular Diseases 119
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors 118
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes 118
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 113
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia 110
Circulating biomarkers of inflammaging and Alzheimer’s disease to track age-related trajectories of dementia: Can we develop a clinically relevant composite combination? 106
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 106
Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk 102
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 100
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 97
Multi-omics strategies to decode the molecular landscape of cellular senescence 91
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 85
Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine 80
On the wake of metformin: Do anti-diabetic SGLT2 inhibitors exert anti-aging effects? 80
Cardioprotective mechanism of ω-3 fatty acid icosapent ethyl (IPE) in cardiomyocytes: role in high glucose and shear stress-induced mechano-transduction dysregulation 76
Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes 65
Age-related adiponectin resistance in human skeletal muscle dysfunction: in vivo and in vitro evidence 49
Microplastics and Atherosclerosis: Mechanisms 48
Electron Microscopy and Multi-Omics Reveal Mitochondrial Dysfunction and Structural Remodeling in the Hearts of Elderly Mice 35
Correction to: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) (Cardiovascular Diabetology, (2024), 23, 1, (420), 10.1186/s12933-024-02504-8) 29
Totale 8.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.613
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 0 0 0 12 46 8 20 10 16 34 17 63
2022/2023597 40 24 25 23 66 35 31 32 284 11 13 13
2023/2024477 24 30 31 22 77 76 12 15 17 33 42 98
2024/20251.220 53 27 20 57 174 122 200 107 149 105 96 110
2025/20265.231 247 356 282 240 381 2.566 339 301 178 193 93 55
2026/2027839 57 92 286 404 0 0 0 0 0 0 0 0
Totale 8.962